Continually Updated Clinical Reference
 
 
  All Sources     eMedicine     Medscape     Drug Reference     MEDLINE
 
eMedicine - Frostbite : Article by

Quick Find
Authors & Editors
Introduction
Clinical
Differentials
Workup
Treatment
Medication
Follow-up
Multimedia
References

Related Articles
Hypothermia




Patient Education
Environmental Exposures and Injuries Center

Infections Center

Frostbite Overview

Frostbite Causes

Frostbite Symptoms

Frostbite Treatment

Tetanus Overview




Author: C Crawford Mechem, MD, MS, FACEP, Associate Professor, Department of Emergency Medicine, University of Pennsylvania School of Medicine; Emergency Medical Services Medical Director, Philadelphia Fire Department

C Crawford Mechem is a member of the following medical societies: American College of Emergency Physicians, National Association of EMS Physicians, and Society for Academic Emergency Medicine

Editors: Michelle Ervin, MD, Chair, Department of Emergency Medicine, Howard University Hospital; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; James S Walker, DO, Program Coordinator, Associate Professor, Department of Emergency Medicine, University of Oklahoma Health Sciences Center; John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center; Jonathan Adler, MD, Attending Physician, Department of Emergency Medicine, Massachusetts General Hospital; Division of Emergency Medicine, Harvard Medical School

Author and Editor Disclosure

Synonyms and related keywords: freezing of tissue, cold exposure, tissue freezing, cold weather injuries, frostbitten, frostnip, cold-related injury, mountain frostbite, hyperemia, gangrene, skin necrosis, peripheral vascular disease, atherosclerosis, arthritis, diabetes, thyroid disease, frost bite, frostbite, hypoxia, dehydration

Background

Frostbite is a cold-related injury characterized by freezing of tissue. Most cases are encountered in soldiers, in those who work outdoors in the cold, in homeless people, and among winter outdoor enthusiasts. Mountain frostbite is a variation observed among mountain climbers and others exposed to extremely cold temperatures at high altitude. It combines tissue freezing with hypoxia and general body dehydration.

Pathophysiology

Cold exposure leads to ice crystal formation, cellular dehydration, protein denaturation, inhibition of DNA synthesis, abnormal cell wall permeability with resultant osmotic changes, damage to capillaries, and pH changes. Rewarming causes cell swelling, erythrocyte and platelet aggregation, endothelial cell damage, thrombosis, tissue edema, increased compartment space pressure, bleb formation, localized ischemia, and tissue death.

Underlying responses to these injuries include generation of oxygen free radicals, production of prostaglandins and thromboxane A2, release of proteolytic enzymes, and generalized inflammation. Tissue injury is greatest when cooling is slow, cold exposure is prolonged, rate of rewarming is slow, and, especially, when tissue is partially thawed and refreezes.

Frequency

United States

No standardized reporting system exists; thus, true frequency of frostbite in the United States and abroad is unknown. Frostbite is uncommon in most of North America, except for northern states, Alaska, and Canada.

International

In Finland, a nation-wide study of hospital admissions for frostbite from 1986-1995 yielded an incidence of 2.5 cases per 100,000 inhabitants.1

Mortality/Morbidity

  • Frostbite is a disease of morbidity, not mortality. However, when combined with hypothermia or wound-related sepsis, death is possible.
  • Long-term sequelae include paresthesias and sensory deficits, hyperhidrosis or anhidrosis, cracking skin and loss of nails, abnormal color changes indicative of vasospasm, cold sensitivity, joint stiffness, tremor, premature closure of epiphyses in children, osteoporosis, intrinsic muscle atrophy, and phantom pain of amputated extremities.

Race

During the Korean War, frostbite was more common among black soldiers than white soldiers. A US Army study of all cases of cold weather injuries, including frostbite, from 1980-1999 similarly demonstrated that African American men and women were 4 times and 2.2 times, respectively, as likely to sustain cold weather injuries as their white counterparts.2

Arabs appear to be similarly predisposed, as are individuals from warmer climates.

Sex

Most frostbite victims are male. This disparity may result from increased outdoor activity among males as opposed to genetic predisposition.

Age

In one case study, the mean patient age was 41 years.3



History

  • Symptoms affecting frostbitten body parts include the following:
    • Coldness and firmness
    • Stinging, burning, numbness
    • Clumsiness
    • Pain, throbbing, burning, or electric current-like sensations on rewarming

Physical

  • Location
    • While hands and feet are affected most frequently, shins, cheeks, nose, ears, and corneas may be involved.
    • As in thermal burns, frostbite injuries may be classified by degree.
    • First-degree injuries involve the epidermis, while fourth-degree injuries involve the epidermis, dermis, subcutaneous tissue, and deeper structures.
  • Degree of injury
    • First-degree injury - Erythema, edema, waxy appearance, hard white plaques, and sensory deficit
    • Second-degree injury - Erythema, edema, and formation of blisters filled with clear or milky fluid and which are high in thromboxane (These blisters form within 24 hours of injury.)
    • Third-degree injury - Presence of blood-filled blisters, which progress to a black eschar over a matter of weeks
    • Fourth-degree injury - Full-thickness damage affecting muscles, tendons, and bone, with resultant tissue loss
  • Other signs
    • Excessive sweating
    • Joint pain
    • Pallor or blue discoloration
    • Hyperemia
    • Skin necrosis
    • Gangrene

Causes

  • Predisposing factors and populations at greatest risk include the following:
    • Individuals stranded in cold weather
    • Soldiers, cold weather rescuers, and laborers working in a cold environment
    • Winter and high-altitude athletes
    • Extremes of age
    • Homelessness
    • Altered mental status (eg, head trauma, ethanol or illicit drug abuse, psychiatric illness)
    • Exposure to water or dampness
    • Immobilization
    • Use of nicotine or other vasoconstrictive drugs
    • Previous cold injury
    • Use of inadequate or constrictive clothing
    • Persons exposed to chronic hand or arm vibration
  • Underlying illness
    • Malnutrition
    • Infection
    • Peripheral vascular disease
    • Atherosclerosis
    • Arthritis
    • Diabetes
    • Thyroid disease



Hypothermia

Other Problems to be Considered

Pernio (chilblains)
Trench foot
Frostnip



Lab Studies

  • Lab studies are not important in the initial diagnosis and management of frostbite. However, they may be helpful in identifying delayed systemic complications, such as wound infection with sepsis or underlying hypothermia.
  • Commonly encountered lab findings include evidence of hemoconcentration and depressed liver function.

Imaging Studies

  • Tc-99m (Technetium 99) pertechnetate scintigraphy is sensitive and specific for tissue injury. Some studies have shown good correlation between scintigraphy findings at 48 hours after injury and ultimate extent of deep-tissue injury. In addition, scintigraphy is useful in assessing the response of damaged tissue to therapy.
  • Radiographs identify clinically suspected fractures or dislocations but are otherwise rarely useful in initial evaluation. They may assist in the diagnosis of long-term complications, such as osteomyelitis.
  • Arteriography is of limited value because it only images large vessels, not microvasculature. It cannot be used to estimate bone cell perfusion or viability.



Prehospital Care

  • Address life-threatening conditions first.
  • Replace wet clothing with dry, soft clothing to minimize further heat loss.
  • Initiate rewarming of affected area as soon as possible. Do not attempt rewarming if a danger of refreezing is present. Avoid rubbing the affected area with warm hands or snow, as this can cause further injury. If the affected body part is an extremity, wrap it in a blanket for mechanical protection during transport. Avoid alcohol or sedatives, which can enhance heat loss and impair shivering.
  • It is better to walk with frozen feet to shelter than to attempt rewarming at the scene; however, walking on frostbitten feet may cause tissue chipping or fracture.

Emergency Department Care

  • Address life-threatening conditions first. Fluid resuscitation, especially in persons with mountain frostbite, enhances blood flow and tissue perfusion.
  • Rapidly rewarm the affected body part, avoiding further trauma.
    • An appropriate warming technique is the use of a whirlpool bath or tub of water at 40-42°C. Mild antibacterial soap may be added. Avoid warmer temperatures or dry heat because of the risk of thermal injury.
    • If a tub is not available, use warm wet packs at the same temperature.
    • Avoid massaging the affected area, as this can cause further injury.
    • Administer analgesics, such as morphine sulfate, as needed for pain.
  • Thawing usually takes 20-40 minutes and is complete when the distal tip of the affected area flushes. Once thawed, keep the body part on sterile sheets, elevated, and splinted when possible. A cradle may be used over an injured lower extremity to avoid pressure or trauma.
  • Debride clear blisters to prevent thromboxane-mediated tissue injury. Leave hemorrhagic blisters intact to reduce risk of infection.
  • In patients with an associated dislocation, perform reduction as soon as thawing is complete. Manage fractures conservatively until postthaw edema has resolved.

Consultations

  • The only indication for early surgical intervention is debridement of blisters or necrotic tissue and fasciotomy in the case of compartment syndrome. Early surgical consultation for amputation is rarely needed.
  • It often takes 1-3 months for frostbitten tissue to be declared viable. The affected area generally heals or mummifies without surgery. Therefore, unless guided by scintigraphy, delay amputation as long as possible.
  • Lower extremity involvement, infection, and delay in seeking medical attention are associated with an increased risk of operative therapy.
  • Surgical consultation is appropriate for guiding long-term management, including debridement for infections not responding to conservative management or for skin grafting.
  • Hyperbaric oxygen therapy may play a role in the long-term management of frostbite injury. However, the current medical literature on this topic is limited to case reports.



The goals of medical management of frostbite are pain control and prevention of complications, such as further tissue damage or infection.

In addition to the interventions described elsewhere, several medication regimens may be beneficial but have not been prospectively validated and doses standardized. These include the daily infusion of low molecular weight dextran, which may prevent erythrocyte clumping in cold-injured blood vessels. Low-dose infusions of heparin may prevent microthrombosis. Recent research suggests that intravenous heparin combined with intravenous tissue plasminogen activator (tPA) may improve outcome in patients with frostbite of the digits. Finally, bupivacaine has been used for either cervical or lumbar sympathetic blockade to decrease sympathetic tone and relieve pain, but its efficacy is unclear.

Drug Category: Nonsteroidal anti-inflammatory drugs (NSAIDs)

These drugs have analgesic and antipyretic activities. Their mechanism of action is not known, but these agents may inhibit cyclooxygenase activity and prostaglandin synthesis.

Other mechanisms may exist as well, such as inhibition of leukotriene synthesis, lysosomal enzyme release, lipoxygenase activity, neutrophil and platelet aggregation, and various cell-membrane functions.

Drug NameIbuprofen (Ibuprin, Advil, Motrin)
DescriptionPreferable to aspirin, which irreversibly blocks synthesis of prostaglandins needed for normal cell function and integrity. Inhibits inflammatory reactions and pain by decreasing prostaglandin synthesis.
Adult Dose400 mg PO q6-8h
Pediatric Dose<6 months: Not established
6 months to 12 years: 20-40 mg/kg/d divided tid/qid
>12 years: 400 mg PO q6-8h
ContraindicationsDocumented hypersensitivity; peptic ulcer disease; recent GI bleeding or perforation; renal insufficiency; high risk of bleeding
InteractionsCoadministration with aspirin increases risk of inducing serious NSAID-related adverse effects; probenecid may increase concentrations and toxicity of NSAIDs; may decrease effect of hydralazine, captopril, and beta-blockers; may decrease diuretic effects of furosemide and thiazides; monitor PT closely (instruct patients to watch for signs of bleeding); may increase risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently
PregnancyB - Usually safe but benefits must outweigh the risks.
PrecautionsCategory D in third trimester of pregnancy; caution in congestive heart failure, hypertension, and decreased renal and hepatic function; caution in anticoagulation abnormalities or during anticoagulant therapy

Drug Category: Antibiotics

These agents are used for wound infection prophylaxis. Their use is controversial and not recommended by some experts unless signs of infection develop.

Drug NamePenicillin G (Pfizerpen)
DescriptionInterferes with synthesis of cell wall mucopeptide during active replication, resulting in bactericidal activity against susceptible microorganisms.
Adult Dose500,000 U IV q6h until edema resolves
Pediatric Dose25,000-50,000 U/kg q6h IM to maximum of 2.4 million U
ContraindicationsDocumented hypersensitivity
InteractionsProbenecid can increase effects of penicillin; coadministration of tetracyclines can decrease effects of penicillin
PregnancyB - Usually safe but benefits must outweigh the risks.
PrecautionsCaution in impaired renal function

Drug Category: Topical agents

These agents are applied to debrided clear blisters and intact hemorrhagic blisters. They minimize further thromboxane synthesis.

Drug NameAloe vera cream
DescriptionUsed to debride blisters and prevent further trauma.
Adult DoseApply to affected area q6h
Pediatric DoseApply as in adults
ContraindicationsDocumented hypersensitivity
InteractionsNone reported
PregnancyA - Safe in pregnancy
PrecautionsFor external use only

Drug Category: Toxoids

These agents are used for tetanus immunization in patients at risk of frostbite-associated tetanus. Booster injection in previously immunized individuals is recommended to prevent this potentially lethal syndrome. These should be supplemented with tetanus Ig, 250 U IM, if patient was never fully immunized.

Drug NameDiphtheria-tetanus toxoid
DescriptionUsed to induce active immunity against tetanus in selected patients. Tetanus and diphtheria toxoids are immunizing agents of choice for most adults and children older than 7 y. Necessary to administer booster doses to maintain tetanus immunity throughout life.
Pregnant patients should receive only tetanus toxoid, not a diphtheria antigen-containing product.
In children and adults, may administer into deltoid or midlateral thigh muscles. In infants, preferred site of administration is the mid thigh laterally.
Adult DosePrimary immunization: 0.5 mL IM; give 2 injections 4-8 wk apart and a third dose 6-12 mo after second injection
Booster dose: 0.5 mL q10y
Pediatric DoseAdminister as in adults
ContraindicationsDocumented hypersensitivity; history of any type of neurologic symptoms or signs following administration of this product; FDA recommends that elective tetanus immunization be deferred during any outbreak of poliomyelitis because tetanus toxoid injections are an important cause of provocative poliomyelitis
InteractionsPatients receiving immunosuppressants, including corticosteroids or radiation therapy, may remain susceptible despite immunization due to poor immune response; cimetidine may enhance or augment delayed-hypersensitivity responses to skin-test antigens; avoid concurrent use of medication with systemic chloramphenicol since it may impair amnestic response to tetanus toxoid; concurrent use of tetanus immune globulin may delay development of active immunity by several days (interaction is nevertheless clinically insignificant and does not preclude its concurrent use)
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsNot for use to treat actual tetanus infections or for immediate prophylaxis of unimmunized individuals (instead use tetanus antitoxin, preferably human tetanus immune globulin); routine immunization of symptomatic and asymptomatic patients infected with HIV recommended

Drug Category: Immune globulins

Patients who may not have been immunized against C tetani products should receive tetanus Ig (Hyper-Tet).

Drug NameTetanus immune globulin (Hyper-Tet)
DescriptionUsed for passive immunization of any person with a wound that may be contaminated with tetanus spores.
Adult DoseProphylaxis: 250-500 U IM in opposite extremity to tetanus toxoid lesion
Clinical tetanus: 3000-10,000 U IM
Pediatric DoseProphylaxis: 250 U IM in opposite extremity as tetanus toxoid
Clinical tetanus: 3000-10,000 U IM
ContraindicationsBecause antibodies in globulin preparation may interfere with immune response to vaccination, do not administer within 3 mo of live-virus immune globulin administration; may be necessary to revaccinate persons who received immune globulin shortly after live-virus vaccination
InteractionsNone reported
PregnancyC - Safety for use during pregnancy has not been established
PrecautionsPersons with isolated IgA deficiency have potential for developing antibodies to IgA and could have anaphylactic reactions to subsequent administration of blood products that contain IgA; do not perform skin testing because intradermal injection of concentrated gamma globulin may cause localized area of inflammation and can be misinterpreted, causing medication to be withheld from a patient not allergic to this material; true allergic responses to human gamma globulin given in prescribed IM manner are extremely rare; do not admix with other medications because of usual incompatibility

Drug Category: Analgesics

These agents are used for pain control during rewarming.

Drug NameMorphine sulfate (Duramorph, Astramorph, MS Contin)
DescriptionDOC for narcotic analgesia because of its reliable and predictable effects, safety, and ease of reversibility with naloxone.
Morphine sulfate administered IV may be dosed in a number of ways and is commonly titrated until obtaining desired effect.
Adult Dose0.1-0.2 mg/kg IV/IM q4h; best given in doses of 2-4 mg, titrating to effect
Pediatric DoseNeonates: 0.05-0.2 mg/kg IV/IM prn
Children: 0.1-0.2 mg/kg IV/IM q2-4h prn
ContraindicationsDocumented hypersensitivity; hypotension; potentially compromised airway where establishing rapid airway control would be difficult
InteractionsPhenothiazines may antagonize analgesic effects of opiate agonists; tricyclic antidepressants, MAO inhibitors, and other CNS depressants may potentiate adverse effects of morphine
PregnancyC - Safety for use during pregnancy has not been established
PrecautionsAvoid in hypotension, respiratory depression, nausea, emesis, constipation, and urinary retention; caution in atrial flutter and other supraventricular tachycardias; has vagolytic action and may increase ventricular response rate



Further Inpatient Care

  • Place the patient on a high-protein, high-calorie diet to promote healing.
  • Place cotton pledgets between frostbitten digits to decrease tissue maceration.
  • Encourage active motion of the affected part as soon as possible.
  • Continue whirlpool baths twice a day, adding surgical soap to the water.
  • Discourage the patient from smoking.

Further Outpatient Care

  • Strongly counsel patients with frostbite regarding their increased susceptibility to frostbite injury and appropriate techniques to avoid cold.
  • Advise patients that the frostbitten area may be more sensitive to cold, with associated burning and tingling.

In/Out Patient Meds

  • The patient's hospital course dictates choice of outpatient medications and may include antibiotics, analgesics, and ibuprofen.

Transfer

  • Transfer the patient to another facility if treating personnel are unfamiliar with management of frostbite and its sequelae. In some settings, burn units have particular expertise in managing severe frostbite injuries. In one report, 29% of homeless patients admitted to a burn unit were admitted for frostbite.4 Therefore, transfer to a facility with a burn unit may be considered.

Complications

  • Wound infection (observed in 30% of patients in one case series; may be the result of Staphylococcus aureus, beta-hemolytic streptococci, gram-negative rods, or anaerobes5)
  • Tetanus (Frostbite is considered a high-risk wound.)
  • Hyperglycemia
  • Acidosis
  • Refractory dysrhythmias
  • Tissue loss
  • Gangrene
  • Death

Prognosis

  • Favorable prognostic signs
    • Early sensation to pinprick
    • Healthy-appearing skin color
    • Clear rather than hemorrhagic blebs
  • Poor prognostic signs
    • Cyanosis
    • Hemorrhagic blebs that do not extend to tips of digits
    • Frozen appearance of tissue

Patient Education

  • Cold weather
    • The primary defense against frostbite is to get out of the cold. If this is not possible, preplanning and use of appropriate clothing are mandatory. Follow weather forecasts, with special attention to both predicted temperature as well as wind-chill temperature index.
    • Cover head, neck, and face in windy conditions. Avoid tight-fitting clothing, particularly on hands and feet. Keep hands and feet dry. Wear mittens instead of gloves. Wear clothing in multiple layers. Avoid perspiration by using adequately ventilated clothing.
    • Increase fluid and caloric intake in cold weather.
    • Do not wash hands, face, or feet frequently under extreme cold conditions, as weather-beaten skin is more resistant to frostbite.
    • Avoid alcohol and tobacco.
    • Keep toenails and fingernails trimmed.
    • Keep tetanus immunization status current.
    • In remote areas, use a buddy system to help prevent cold injury. Have a system for rapid evacuation, if needed.
    • At high altitudes, individuals should moderate their activity to minimize the work of breathing and associated heat loss through the respiratory tree. Use of supplemental oxygen has been found to reduce the incidence of frostbite among mountain climbers.
  • For excellent patient education resources, visit eMedicine's Environmental Exposures and Injuries Center and Infections Center. Also, see eMedicine's patient education articles Frostbite and Tetanus.



Media file 1:  Frostbite of the foot. Photo courtesy of Kevin P. Kilgore, MD, Department of Emergency Medicine, Regions Hospital.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Photo

Media file 2:  Frostbite of the ear. Photo courtesy of Kevin P. Kilgore, MD, Department of Emergency Medicine, Regions Hospital.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Photo

Media file 3:  Frostbite of the hand.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Photo



  1. Juopperi K, Hassi J, Ervasti O, Drebs A, Nayha S. Incidence of frostbite and ambient temperature in Finland, 1986-1995. A national study based on hospital admissions. Int J Circumpolar Health. Nov 2002;61(4):352-62. [Medline].
  2. DeGroot DW, Castellani JW, Williams JO, Amoroso PJ. Epidemiology of U.S. Army cold weather injuries, 1980-1999. Aviat Space Environ Med. May 2003;74(5):564-70. [Medline].
  3. Valnicek SM, Chasmar LR, Clapson JB. Frostbite in the prairies: a 12-year review. Plast Reconstr Surg. Sep 1993;92(4):633-41. [Medline].
  4. Kowal-Vern A, Latenser BA. Demographics of the homeless in an urban burn unit. J Burn Care Res. Jan-Feb 2007;28(1):105-10. [Medline].
  5. Rabold MB. Frostbite and other localized cold-related injuries. In: Tintinalli JE, ed. Emergency Medicine: A Comprehensive Study Guide. 6th ed. New York: McGraw-Hill; 2004:1175-1179.
  6. Bhatnagar A, Sarker BB, Sawroop K, Chopra MK, Sinha N, Kashyap R. Diagnosis, characterisation and evaluation of treatment response of frostbite using pertechnetate scintigraphy: a prospective study. Eur J Nucl Med Mol Imaging. Feb 2002;29(2):170-5. [Medline].
  7. Britt LD, Dascombe WH, Rodriguez A. New horizons in management of hypothermia and frostbite injury. Surg Clin North Am. Apr 1991;71(2):345-70. [Medline].
  8. Castellani JW, Young AJ, Ducharme MB, Giesbrecht GG, Glickman E, Sallis RE, et al. American College of Sports Medicine position stand: prevention of cold injuries during exercise. Med Sci Sports Exerc. Nov 2006;38(11):2012-29. [Medline].
  9. Chan TY, Smedley FH. Tetanus complicating frostbite. Injury. Jul 1990;21(4):245. [Medline].
  10. Ervasti O, Juopperi K, Kettunen P, Remes J, Rintamaki H, Latvala J, et al. The occurrence of frostbite and its risk factors in young men. Int J Circumpolar Health. Mar 2004;63(1):71-80. [Medline].
  11. Finderle Z, Cankar K. Delayed treatment of frostbite injury with hyperbaric oxygen therapy: a case report. Aviat Space Environ Med. Apr 2002;73(4):392-4. [Medline].
  12. Hamlet MP. Prevention and treatment of cold injury. Int J Circumpolar Health. Apr 2000;59(2):108-13. [Medline].
  13. Hashmi MA, Rashid M, Haleem A, Bokhari SA, Hussain T. Frostbite: epidemiology at high altitude in the Karakoram mountains. Ann R Coll Surg Engl. Mar 1998;80(2):91-5. [Medline].
  14. Hassi J, Makinen TM. Frostbite: occurrence, risk factors and consequences. Int J Circumpolar Health. Apr 2000;59(2):92-8. [Medline].
  15. Heggers JP, Robson MC, Manavalen K, Weingarten MD, Carethers JM, Boertman JA, et al. Experimental and clinical observations on frostbite. Ann Emerg Med. Sep 1987;16(9):1056-62. [Medline].
  16. Kanzenbach TL, Dexter WW. Cold injuries. Protecting your patients from the dangers of hypothermia and frostbite. Postgrad Med. Jan 1999;105(1):72-8. [Medline].
  17. Kupper T, Steffgen J, Jansing P. Cold exposure during helicopter rescue operations in the Western Alps. Ann Occup Hyg. Jan 2003;47(1):7-16. [Medline].
  18. McCauley RL, Smith DJ, Robson MC. Frostbite and other cold-induced injuries. In: Auerbach PS, ed. Wilderness Medicine. 3rd ed. St Louis: Mosby; 1995:129-145.
  19. Mehta RC, Wilson MA. Frostbite injury: prediction of tissue viability with triple-phase bone scanning. Radiology. Feb 1989;170(2):511-4. [Medline].
  20. Mills WJ Jr. Summary of treatment of the cold injured patient: frostbite. 1983. Alaska Med. Jan-Mar 1993;35(1):61-6. [Medline].
  21. Petrone P, Kuncir EJ, Asensio JA. Surgical management and strategies in the treatment of hypothermia and cold injury. Emerg Med Clin North Am. Nov 2003;21(4):1165-78. [Medline].
  22. Pulla RJ, Pickard LJ, Carnett TS. Frostbite: an overview with case presentations. J Foot Ankle Surg. Jan-Feb 1994;33(1):53-63. [Medline].
  23. Reamy BV. Frostbite: review and current concepts. J Am Board Fam Pract. Jan-Feb 1998;11(1):34-40. [Medline].
  24. Schissel DJ, Barney DL, Keller R. Cold weather injuries in an arctic environment. Mil Med. Aug 1998;163(8):568-71. [Medline].
  25. Twomey JA, Peltier GL, Zera RT. An open-label study to evaluate the safety and efficacy of tissue plasminogen activator in treatment of severe frostbite. J Trauma. Dec 2005;59(6):1350-4; discussion 1354-5. [Medline].
  26. Urschel JD. Frostbite: predisposing factors and predictors of poor outcome. J Trauma. Mar 1990;30(3):340-2. [Medline].
  27. Vogel JE, Dellon AL. Frostbite injuries of the hand. Clin Plast Surg. Jul 1989;16(3):565-76. [Medline].

Frostbite excerpt

Article Last Updated: Jul 18, 2007